Amarin | Passività Correnti



Current Liabilities Cambiamento Data
AbbVie USD 38.75B 4.31B 2024-12
Alnylam Pharmaceuticals USD 1.08B 110.65M 2025-03
Amarin USD 162.41M 17.54M 2025-03
AstraZeneca USD 29.13B 1.26B 2025-03
DBV Technologies USD 40.38M 9.25M 2025-03
GlaxoSmithKline GBP 20.83B 866M 2025-03
Halozyme Therapeutics USD 150.38M 11.28M 2025-03
Ionis Pharmaceuticals USD 250.29M 59.02M 2025-03
Neurocrine Biosciences USD 507.7M 78M 2024-12
Novartis USD 28.69B 560M 2024-12



Amarin Passività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Jul 2025.